AOL

A world-first 'human challenge' trial will infect healthy young people with coronavirus to study how it spreads and which vaccines work best

Visit the Business section of Insider for more stories. A world-first study will infect young, healthy people with coronavirus in a controlled environment to learn more about its characteristics, UK ...
Seeking Alpha

Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A

BOTHELL, Wash., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (COCP) (“Cocrystal” or the “Company”) announces the achievement of first-patient-in for the Phase 2a human challenge clinical ...
FOX40 News

Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference

Neumifil delivers statistically significant reductions in influenza symptomatic infection rate, symptom severity and viral load Strategy to advance clinical development of Neumifil to be based on ...
EurekAlert!

Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza

Two Eradivir employees conduct research on the company’s EV25 influenza therapeutic. Eradivir, a clinical stage biotech company, will begin a Phase 2 challenge study with its antiviral therapeutic, ...